Intersect ENT, Inc. (XENT): Price and Financial Metrics
Today's Latest Price: $19.28 USD
Dec 1 4:00pm Add XENT to Watchlist Sign Up
XENT Stock Summary XENT's price/sales ratio is 7.5; that's higher than the P/S ratio of 81.01% of US stocks. With a year-over-year growth in debt of 599.93%, Intersect ENT Inc's debt growth rate surpasses 96.89% of about US stocks. As for revenue growth, note that XENT's revenue has grown -23.68% over the past 12 months; that beats the revenue growth of just 15.01% of US companies in our set. Stocks that are quantitatively similar to XENT, based on their financial statements, market capitalization, and price volatility, are CNTG, RMED, ECOR, QUOT, and REFR. Visit XENT's SEC page to see the company's official filings. To visit the company's web site, go to www.intersectent.com.
XENT Price/Volume Stats
Intersect ENT, Inc. (XENT) Company Bio
Intersect ENT provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. The company was founded in 2003 and is based in Menlo Park, California.
XENT Latest News Stream
All News Types
Downgrade Earnings Guidance Down Guidance Up New Coverage (Bullish) New Coverage (Neutral) Product News PT Lowered PT Raised PT Set (Bullish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Upgrade
Loading, please wait...
Latest XENT News From Around the Web
Below are the latest news stories about Intersect ENT Inc that investors may wish to consider to help them evaluate XENT as an investment opportunity.
MENLO PARK, Calif. and BERLIN--(BUSINESS WIRE)--Intersect ENT Announces Agreement to Acquire Fiagon AG Medical Technologies for €60 Million Paid Over Three Years
Intersect ENT ([[XENT]] +4.3%) has executed a pharmacy services agreement with AllianceRx Walgreens Prime for national specialty pharmacy distribution of the Company’s SINUVA (mometasone furoate) Sinus Implant.The agreement will facilitate broader physician and patient access to SINUVA through either a patient’s medical or pharmacy insurance benefit.SINUVA is a non-surgical, corticosteroid-eluting implant...
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) Agenus Inc (NASDAQ: AGEN ) Akouos Inc (NASDAQ: AKUS ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Trillium Therapeutics Inc (NASDAQ: TRIL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 10) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC )(reac...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT Announces Specialty Pharmacy Partnership Agreement with AllianceRx Walgreens Prime to Distribute SINUVA® Sinus Implant
Intersect ENT, Inc. (XENT) Q2 2020 Results Earnings Conference Call August 04, 2020, 08:30 AM ET Company Participants Richard Meier - Executive VP & CFO Thomas West - President & CEO Conference Call Participants Chris Pasquale - Guggenheim Ravi Misra - Berenberg Suraj Kalia - Oppenheimer & Company. Presentation Operator...
Read More 'XENT' Stories Here
XENT Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.9135 seconds.